Trial Profile
Effect of sunitinib, as first-line chemotherapy, on PD-1 and PD-L1 expression in primary metastatic clear cell renal cell carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Clear cell sarcoma; Renal cell carcinoma
- Focus Therapeutic Use
- 05 Dec 2015 New trial record